Skip to main content

Trade-Ideas LLC identified

BioMed Realty

(

BMR

) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified BioMed Realty as such a stock due to the following factors:

  • BMR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $62.0 million.
  • BMR traded 319,205 shares today in the pre-market hours as of 7:41 AM, representing 12% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BMR with the Ticky from Trade-Ideas. See the FREE profile for BMR NOW at Trade-Ideas

More details on BMR:

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The stock currently has a dividend yield of 4.9%. BMR has a PE ratio of 21. Currently there are 6 analysts that rate BioMed Realty a buy, no analysts rate it a sell, and 5 rate it a hold.

The average volume for BioMed Realty has been 1.9 million shares per day over the past 30 days. BioMed has a market cap of $4.3 billion and is part of the financial sector and real estate industry. The stock has a beta of 0.43 and a short float of 4.9% with 2.75 days to cover. Shares are down 0.7% year-to-date as of the close of trading on Tuesday.

TheStreet Recommends

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates BioMed Realty as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, reasonable valuation levels and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including poor profit margins and weak operating cash flow.

Highlights from the ratings report include:

  • The net income growth from the same quarter one year ago has greatly exceeded that of the S&P 500, but is less than that of the Real Estate Investment Trusts (REITs) industry average. The net income increased by 26.5% when compared to the same quarter one year prior, rising from $18.64 million to $23.58 million.
  • BMR, with its decline in revenue, underperformed when compared the industry average of 9.8%. Since the same quarter one year prior, revenues slightly dropped by 7.6%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.
  • The gross profit margin for BIOMED REALTY TRUST INC is currently extremely low, coming in at 4.11%. It has decreased significantly from the same period last year. Along with this, the net profit margin of 14.91% significantly trails the industry average.
  • Net operating cash flow has decreased to $55.49 million or 23.60% when compared to the same quarter last year. In addition, when comparing the cash generation rate to the industry average, the firm's growth is significantly lower.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.